These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 15255263)

  • 1. Life span extension and reduced neuronal death after weekly intraventricular cyclosporin injections in the G93A transgenic mouse model of amyotrophic lateral sclerosis.
    Karlsson J; Fong KS; Hansson MJ; Elmér E; Csiszar K; Keep MF
    J Neurosurg; 2004 Jul; 101(1):128-37. PubMed ID: 15255263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. n-butylidenephthalide treatment prolongs life span and attenuates motor neuron loss in SOD1
    Zhou QM; Zhang JJ; Li S; Chen S; Le WD
    CNS Neurosci Ther; 2017 May; 23(5):375-385. PubMed ID: 28229532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrathecal cyclosporin prolongs survival of late-stage ALS mice.
    Keep M; Elmér E; Fong KS; Csiszar K
    Brain Res; 2001 Mar; 894(2):327-31. PubMed ID: 11251210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic benefits of putrescine-modified catalase in a transgenic mouse model of familial amyotrophic lateral sclerosis.
    Reinholz MM; Merkle CM; Poduslo JF
    Exp Neurol; 1999 Sep; 159(1):204-16. PubMed ID: 10486188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscle-derived but not centrally derived transgene GDNF is neuroprotective in G93A-SOD1 mouse model of ALS.
    Li W; Brakefield D; Pan Y; Hunter D; Myckatyn TM; Parsadanian A
    Exp Neurol; 2007 Feb; 203(2):457-71. PubMed ID: 17034790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partial deficiency of manganese superoxide dismutase exacerbates a transgenic mouse model of amyotrophic lateral sclerosis.
    Andreassen OA; Ferrante RJ; Klivenyi P; Klein AM; Shinobu LA; Epstein CJ; Beal MF
    Ann Neurol; 2000 Apr; 47(4):447-55. PubMed ID: 10762155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis.
    Klivenyi P; Ferrante RJ; Matthews RT; Bogdanov MB; Klein AM; Andreassen OA; Mueller G; Wermer M; Kaddurah-Daouk R; Beal MF
    Nat Med; 1999 Mar; 5(3):347-50. PubMed ID: 10086395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uridine ameliorates the pathological phenotype in transgenic G93A-ALS mice.
    Amante DJ; Kim J; Carreiro ST; Cooper AC; Jones SW; Li T; Moody JP; Edgerly CK; Bordiuk OL; Cormier K; Smith K; Ferrante RJ; Rusche J
    Amyotroph Lateral Scler; 2010 Dec; 11(6):520-30. PubMed ID: 20565334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Light therapy and supplementary Riboflavin in the SOD1 transgenic mouse model of familial amyotrophic lateral sclerosis (FALS).
    Moges H; Vasconcelos OM; Campbell WW; Borke RC; McCoy JA; Kaczmarczyk L; Feng J; Anders JJ
    Lasers Surg Med; 2009 Jan; 41(1):52-9. PubMed ID: 19143012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study of the purine derivative AIT-082 in G93A SOD1 transgenic mice.
    Jiang F; Li WP; Kwiecien J; Turnbull J
    Int J Immunopathol Pharmacol; 2006; 19(3):489-98. PubMed ID: 17026833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of rosmarinic acid in motor dysfunction and life span in a mouse model of familial amyotrophic lateral sclerosis.
    Shimojo Y; Kosaka K; Noda Y; Shimizu T; Shirasawa T
    J Neurosci Res; 2010 Mar; 88(4):896-904. PubMed ID: 19798750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic effects of clenbuterol in a murine model of amyotrophic lateral sclerosis.
    Teng YD; Choi H; Huang W; Onario RC; Frontera WR; Snyder EY; Sabharwal S
    Neurosci Lett; 2006 Apr 10-17; 397(1-2):155-8. PubMed ID: 16388902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L-carnitine suppresses the onset of neuromuscular degeneration and increases the life span of mice with familial amyotrophic lateral sclerosis.
    Kira Y; Nishikawa M; Ochi A; Sato E; Inoue M
    Brain Res; 2006 Jan; 1070(1):206-14. PubMed ID: 16412993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opposing effects of low and high-dose clozapine on survival of transgenic amyotrophic lateral sclerosis mice.
    Turner BJ; Rembach A; Spark R; Lopes EC; Cheema SS
    J Neurosci Res; 2003 Nov; 74(4):605-13. PubMed ID: 14598305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic effects of dl-3-n-butylphthalide in a transgenic mouse model of amyotrophic lateral sclerosis.
    Feng XH; Yuan W; Peng Y; Liu MS; Cui LY
    Chin Med J (Engl); 2012 May; 125(10):1760-6. PubMed ID: 22800896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotective effects of diallyl trisulfide in SOD1-G93A transgenic mouse model of amyotrophic lateral sclerosis.
    Guo Y; Zhang K; Wang Q; Li Z; Yin Y; Xu Q; Duan W; Li C
    Brain Res; 2011 Feb; 1374():110-5. PubMed ID: 21147075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined riluzole and sodium phenylbutyrate therapy in transgenic amyotrophic lateral sclerosis mice.
    Del Signore SJ; Amante DJ; Kim J; Stack EC; Goodrich S; Cormier K; Smith K; Cudkowicz ME; Ferrante RJ
    Amyotroph Lateral Scler; 2009 Apr; 10(2):85-94. PubMed ID: 18618304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of oxygen radical-induced lipid peroxidative damage to disease onset and progression in a transgenic model of familial ALS.
    Hall ED; Andrus PK; Oostveen JA; Fleck TJ; Gurney ME
    J Neurosci Res; 1998 Jul; 53(1):66-77. PubMed ID: 9670993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ivermectin inhibits AMPA receptor-mediated excitotoxicity in cultured motor neurons and extends the life span of a transgenic mouse model of amyotrophic lateral sclerosis.
    Andries M; Van Damme P; Robberecht W; Van Den Bosch L
    Neurobiol Dis; 2007 Jan; 25(1):8-16. PubMed ID: 17045808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beneficial effects of lysine acetylsalicylate, a soluble salt of aspirin, on motor performance in a transgenic model of amyotrophic lateral sclerosis.
    Barnéoud P; Curet O
    Exp Neurol; 1999 Feb; 155(2):243-51. PubMed ID: 10072299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.